FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079266147> ?p ?o ?g. }

• W2079266147 endingPage "240.e15" @default.
• W2079266147 startingPage "240.e9" @default.
• W2079266147 abstract "Objective To test the efficiency of 6 mRNA bladder markers in staging urothelial cell carcinoma (UCC) and monitoring UCC dissemination from blood samples. Methods From 2002 to 2009, 347 blood samples were collected from 150 patients with UCC and 29 healthy controls. Sequential blood sampling was performed in patients undergoing cystectomy at surgery and 6, 12, 18, and 24 months postoperatively. The median follow-up was 33 months. The presence of KRT20, FXYD3, C10orf116, UPK2, AGR2, and KRT19 markers in blood was evaluated in all patients and controls by measuring the gene expression using preamplified cDNA and reverse transcriptase quantitative polymerase chain reaction. Gene expression data were correlated with the tumor risk, follow-up, and outcomes data. Results Expression of C10orf116 and KRT19 genes differed between patients and controls (P < .001). KRT20, C10orf116, and AGR2 differentiated between low- and high-risk nonmuscle-invasive bladder cancer (P = .001, P = .011, and P = .001, respectively). FXYD3 differentiated between patients with high-risk nonmuscle-invasive bladder cancer and those with muscle-invasive bladder cancer (P = .009). In contrast, the 6 markers showed no differences in gene expression between metastatic and patients without metastases who had not undergone cystectomy (P = NS). None of the markers were significantly increased in the metastatic patients at 6, 12, 18, or 24 months after surgery. Conclusion The gene expression of bladder-specific mRNA markers in blood was different among the various tumor risk groups of patients with UCC. However, this gene expression analysis is not suitable for predicting metastases or monitoring UCC hematogenous dissemination in patients who have undergone cystectomy. To test the efficiency of 6 mRNA bladder markers in staging urothelial cell carcinoma (UCC) and monitoring UCC dissemination from blood samples. From 2002 to 2009, 347 blood samples were collected from 150 patients with UCC and 29 healthy controls. Sequential blood sampling was performed in patients undergoing cystectomy at surgery and 6, 12, 18, and 24 months postoperatively. The median follow-up was 33 months. The presence of KRT20, FXYD3, C10orf116, UPK2, AGR2, and KRT19 markers in blood was evaluated in all patients and controls by measuring the gene expression using preamplified cDNA and reverse transcriptase quantitative polymerase chain reaction. Gene expression data were correlated with the tumor risk, follow-up, and outcomes data. Expression of C10orf116 and KRT19 genes differed between patients and controls (P < .001). KRT20, C10orf116, and AGR2 differentiated between low- and high-risk nonmuscle-invasive bladder cancer (P = .001, P = .011, and P = .001, respectively). FXYD3 differentiated between patients with high-risk nonmuscle-invasive bladder cancer and those with muscle-invasive bladder cancer (P = .009). In contrast, the 6 markers showed no differences in gene expression between metastatic and patients without metastases who had not undergone cystectomy (P = NS). None of the markers were significantly increased in the metastatic patients at 6, 12, 18, or 24 months after surgery. The gene expression of bladder-specific mRNA markers in blood was different among the various tumor risk groups of patients with UCC. However, this gene expression analysis is not suitable for predicting metastases or monitoring UCC hematogenous dissemination in patients who have undergone cystectomy." @default.
• W2079266147 created "2016-06-24" @default.
• W2079266147 creator A5001340494 @default.
• W2079266147 creator A5008420331 @default.
• W2079266147 creator A5009147832 @default.
• W2079266147 creator A5027548324 @default.
• W2079266147 creator A5042997499 @default.
• W2079266147 creator A5045031134 @default.
• W2079266147 creator A5063808760 @default.
• W2079266147 creator A5085349056 @default.
• W2079266147 date "2012-01-01" @default.
• W2079266147 modified "2023-10-08" @default.
• W2079266147 title "Utility of Urothelial mRNA Markers in Blood for Staging and Monitoring Bladder Cancer" @default.
• W2079266147 cites W1978368163 @default.
• W2079266147 cites W2000103212 @default.
• W2079266147 cites W2002941602 @default.
• W2079266147 cites W2003129076 @default.
• W2079266147 cites W2022503705 @default.
• W2079266147 cites W2031726925 @default.
• W2079266147 cites W2050547995 @default.
• W2079266147 cites W2078807996 @default.
• W2079266147 cites W2079444664 @default.
• W2079266147 cites W2086918041 @default.
• W2079266147 cites W2093921289 @default.
• W2079266147 cites W2100480913 @default.
• W2079266147 cites W2106811313 @default.
• W2079266147 cites W2107539543 @default.
• W2079266147 cites W2110008907 @default.
• W2079266147 cites W2111976640 @default.
• W2079266147 cites W2120680169 @default.
• W2079266147 cites W2122588125 @default.
• W2079266147 cites W2126242725 @default.
• W2079266147 cites W2131098924 @default.
• W2079266147 cites W2131967611 @default.
• W2079266147 cites W2141324982 @default.
• W2079266147 cites W2165980079 @default.
• W2079266147 cites W4231150365 @default.
• W2079266147 doi "https://doi.org/10.1016/j.urology.2011.09.006" @default.
• W2079266147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22055693" @default.
• W2079266147 hasPublicationYear "2012" @default.
• W2079266147 type Work @default.
• W2079266147 sameAs 2079266147 @default.
• W2079266147 citedByCount "18" @default.
• W2079266147 countsByYear W20792661472012 @default.
• W2079266147 countsByYear W20792661472013 @default.
• W2079266147 countsByYear W20792661472014 @default.
• W2079266147 countsByYear W20792661472015 @default.
• W2079266147 countsByYear W20792661472017 @default.
• W2079266147 countsByYear W20792661472019 @default.
• W2079266147 countsByYear W20792661472020 @default.
• W2079266147 countsByYear W20792661472021 @default.
• W2079266147 crossrefType "journal-article" @default.
• W2079266147 hasAuthorship W2079266147A5001340494 @default.
• W2079266147 hasAuthorship W2079266147A5008420331 @default.
• W2079266147 hasAuthorship W2079266147A5009147832 @default.
• W2079266147 hasAuthorship W2079266147A5027548324 @default.
• W2079266147 hasAuthorship W2079266147A5042997499 @default.
• W2079266147 hasAuthorship W2079266147A5045031134 @default.
• W2079266147 hasAuthorship W2079266147A5063808760 @default.
• W2079266147 hasAuthorship W2079266147A5085349056 @default.
• W2079266147 hasConcept C104317684 @default.
• W2079266147 hasConcept C121608353 @default.
• W2079266147 hasConcept C126322002 @default.
• W2079266147 hasConcept C126894567 @default.
• W2079266147 hasConcept C142724271 @default.
• W2079266147 hasConcept C143998085 @default.
• W2079266147 hasConcept C150194340 @default.
• W2079266147 hasConcept C185592680 @default.
• W2079266147 hasConcept C2775910329 @default.
• W2079266147 hasConcept C2780352672 @default.
• W2079266147 hasConcept C2988731192 @default.
• W2079266147 hasConcept C48023723 @default.
• W2079266147 hasConcept C55493867 @default.
• W2079266147 hasConcept C71924100 @default.
• W2079266147 hasConceptScore W2079266147C104317684 @default.
• W2079266147 hasConceptScore W2079266147C121608353 @default.
• W2079266147 hasConceptScore W2079266147C126322002 @default.
• W2079266147 hasConceptScore W2079266147C126894567 @default.
• W2079266147 hasConceptScore W2079266147C142724271 @default.
• W2079266147 hasConceptScore W2079266147C143998085 @default.
• W2079266147 hasConceptScore W2079266147C150194340 @default.
• W2079266147 hasConceptScore W2079266147C185592680 @default.
• W2079266147 hasConceptScore W2079266147C2775910329 @default.
• W2079266147 hasConceptScore W2079266147C2780352672 @default.
• W2079266147 hasConceptScore W2079266147C2988731192 @default.
• W2079266147 hasConceptScore W2079266147C48023723 @default.
• W2079266147 hasConceptScore W2079266147C55493867 @default.
• W2079266147 hasConceptScore W2079266147C71924100 @default.
• W2079266147 hasIssue "1" @default.
• W2079266147 hasLocation W20792661471 @default.
• W2079266147 hasLocation W20792661472 @default.
• W2079266147 hasOpenAccess W2079266147 @default.
• W2079266147 hasPrimaryLocation W20792661471 @default.
• W2079266147 hasRelatedWork W1992674258 @default.
• W2079266147 hasRelatedWork W2078477972 @default.
• W2079266147 hasRelatedWork W2120921122 @default.
• W2079266147 hasRelatedWork W2331403566 @default.
• W2079266147 hasRelatedWork W2357375221 @default.

• next